Eversept Partners LP Has $44.76 Million Stake in HCA Healthcare, Inc. $HCA

Eversept Partners LP lessened its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 14.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 95,874 shares of the company’s stock after selling 15,826 shares during the quarter. HCA Healthcare makes up 2.3% of Eversept Partners LP’s portfolio, making the stock its 10th biggest position. Eversept Partners LP’s holdings in HCA Healthcare were worth $44,760,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. First Manhattan CO. LLC. grew its stake in HCA Healthcare by 79.6% in the fourth quarter. First Manhattan CO. LLC. now owns 28,783 shares of the company’s stock worth $13,438,000 after purchasing an additional 12,760 shares during the period. Capitolis Liquid Global Markets LLC purchased a new stake in HCA Healthcare in the fourth quarter worth $9,963,000. City National Bank of Florida MSD grew its stake in HCA Healthcare by 8.6% in the fourth quarter. City National Bank of Florida MSD now owns 2,639 shares of the company’s stock worth $1,232,000 after purchasing an additional 209 shares during the period. Banco Bilbao Vizcaya Argentaria S.A. grew its stake in HCA Healthcare by 43.5% in the fourth quarter. Banco Bilbao Vizcaya Argentaria S.A. now owns 41,718 shares of the company’s stock worth $19,479,000 after purchasing an additional 12,650 shares during the period. Finally, Boothbay Fund Management LLC purchased a new stake in shares of HCA Healthcare in the fourth quarter worth $472,000. 62.73% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of equities research analysts have recently commented on the company. Barclays cut their target price on HCA Healthcare from $551.00 to $496.00 and set an “overweight” rating on the stock in a research note on Monday, April 27th. KeyCorp cut their target price on HCA Healthcare from $550.00 to $510.00 and set an “overweight” rating on the stock in a research note on Monday, April 27th. Deutsche Bank Aktiengesellschaft cut their target price on HCA Healthcare from $558.00 to $540.00 and set a “buy” rating on the stock in a research note on Tuesday, April 28th. Royal Bank Of Canada cut their target price on HCA Healthcare from $593.00 to $534.00 and set an “outperform” rating on the stock in a research note on Monday, April 27th. Finally, Weiss Ratings downgraded HCA Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a report on Tuesday, June 9th. Fifteen analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $506.14.

HCA Healthcare Price Performance

Shares of NYSE:HCA opened at $387.87 on Thursday. The company has a market cap of $86.05 billion, a P/E ratio of 13.34, a PEG ratio of 1.26 and a beta of 1.12. HCA Healthcare, Inc. has a 1 year low of $330.00 and a 1 year high of $556.52. The stock’s fifty day moving average price is $424.54 and its 200-day moving average price is $470.67.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Friday, April 24th. The company reported $7.15 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $7.19 by ($0.04). The business had revenue of $19.11 billion for the quarter, compared to the consensus estimate of $19.09 billion. HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The company’s revenue for the quarter was up 4.3% compared to the same quarter last year. During the same period in the previous year, the company earned $6.45 earnings per share. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, sell-side analysts anticipate that HCA Healthcare, Inc. will post 30.07 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, June 30th. Shareholders of record on Tuesday, June 16th will be given a $0.78 dividend. This represents a $3.12 annualized dividend and a yield of 0.8%. The ex-dividend date of this dividend is Tuesday, June 16th. HCA Healthcare’s dividend payout ratio (DPR) is presently 10.73%.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.